U.S. Taps Israel’s Rafa to Advance Prehospital Lifesaving Bleeding Treatment
U.S. taps Israel’s Rafa to advance prehospital lifesaving bleeding treatment with new $186 million contract for intramuscular TXA formulation.
tranexamic acid (TXA)
ناوبری